StockData
Nexalin Technology, Inc. logo

Nexalin Technology, Inc. (NXL) stock

NXLNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/30
$1.44−0.06 (-4.00%)

Close on Nov 18, 2026Market cap $31.73MP/E –Yield –

Nexalin Technology operating margin

Operating margin is operating income as a percentage of revenue.

Nexalin Technology's operating margin for the twelve months ending Jun 30, 2026 was -4202.5%. For fiscal 2025 it was -2781.7%, against -4596.1% the year before. The highest annual figure on record is -138.7% in fiscal 2022.

Annual operating margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-2781.7%+1814.4
FY2024Dec 31, 2024-4596.1%+547.3
FY2023Dec 31, 2023-5143.5%−5004.8
FY2022Dec 31, 2022-138.7%+4039.0
FY2021Dec 31, 2021-4177.7%–

Quarterly operating margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 30, 2026-18479.7%−16183.5
Q1 FY2026Mar 31, 2026-14179.9%−9276.3
Q4 FY2025Dec 31, 2025-1403.9%+9175.6
Q3 FY2025Sep 30, 2025-12924.3%−5962.2
Q2 FY2025Jun 30, 2025-2296.2%+2536.2
Q1 FY2025Mar 31, 2025-4903.6%−3538.8
Q4 FY2024Dec 31, 2024-10579.5%−8112.2
Q3 FY2024Sep 30, 2024-6962.1%−4411.6
Q2 FY2024Jun 30, 2024-4832.4%−2959.6
Q1 FY2024Mar 31, 2024-1364.8%−1311.0
Q2 FY2023Jun 30, 2023-2467.2%−2359.8
Q1 FY2023Mar 31, 2023-2550.5%−2434.5
Q4 FY2022Dec 31, 2022-1872.8%+533.5
Q3 FY2022Sep 30, 2022-53.8%+3154.1
Q2 FY2022Jun 30, 2022-107.4%–
Q1 FY2022Mar 31, 2022-116.0%–
Q4 FY2021Dec 31, 2021-2406.3%–
Q3 FY2021Sep 30, 2021-3207.9%–

More Nexalin Technology figures

See a number that looks wrong?